Terug
82
Dagbereik
€ 47,60
€ 49,98
52-Weeksbereik
€ 36,22
€ 104,32
Volume
4.698.160
50D / 200D Gem.
€ 57,60
/
€ 69,23
Vorige Slotkoers
€ 46,96
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -34,8 | 0,4 |
| P/B | 17,4 | 2,9 |
| ROE % | -89,5 | 3,8 |
| Net Margin % | -19,3 | 3,9 |
| Rev Growth 5Y % | 49,0 | 10,0 |
| D/E | 1,7 | 0,2 |
Koersdoel Analisten
Hold
€ 87,11
+77.3%
Low: € 59,00
High: € 105,00
Forward WPA
-€ 0,40
Omzet Sch.
1,6 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,05
€ 2,93 – € 3,21
|
3,2 B | 2 |
| FY2029 |
€ 1,87
€ 1,80 – € 1,97
|
2,7 B | 4 |
| FY2028 |
€ 0,76
-€ 0,56 – € 1,98
|
2,3 B | 6 |
Belangrijkste Punten
Revenue grew 49,03% annually over 5 years — strong growth
Negative free cash flow of -239,14M
PEG of 0,61 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 34,38%
Capital efficient — spends only 1,66% of revenue on capex
Groei
Revenue Growth (5Y)
49,03%
Revenue (1Y)83,41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-89,48%
ROIC-13,69%
Net Margin-19,27%
Op. Margin-18,76%
Veiligheid
Debt / Equity
1,66
Current Ratio3,13
Interest Coverage-3,40
Waardering
P/E Ratio
-34,84
P/B Ratio17,38
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 83,41% | Revenue Growth (3Y) | 54,64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 49,03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,27B | Net Income (TTM) | -245,03M |
| ROE | -89,48% | ROA | -10,77% |
| Gross Margin | 69,64% | Operating Margin | -18,76% |
| Net Margin | -19,27% | Free Cash Flow (TTM) | -239,14M |
| ROIC | -13,69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,66 | Current Ratio | 3,13 |
| Interest Coverage | -3,40 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -34,84 | P/B Ratio | 17,38 |
| P/S Ratio | 6,71 | PEG Ratio | 0,61 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 8,54B | Enterprise Value | 8,75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,27B | 693,40M | 531,82M | 320,67M | 257,85M |
| Net Income | -245,03M | -705,81M | -214,12M | -289,81M | -259,19M |
| EPS (Diluted) | -1,41 | -4,60 | -1,73 | -1,97 | -1,75 |
| Gross Profit | 885,69M | 381,11M | 286,18M | 130,19M | 83,64M |
| Operating Income | -238,64M | -691,08M | -196,08M | -265,44M | -243,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,27B | 926,12M | 564,05M | 631,36M | 531,35M |
| Total Liabilities | 1,78B | 869,78M | 1,95B | 1,76B | 1,34B |
| Shareholders' Equity | 491,33M | 56,34M | -1,38B | -1,13B | -807,49M |
| Total Debt | 815,71M | 468,09M | 488,14M | 433,03M | 238,95M |
| Cash & Equivalents | 604,79M | 340,95M | 165,77M | 302,94M | 277,69M |
| Current Assets | 1,17B | 667,60M | 350,33M | 438,63M | 403,99M |
| Current Liabilities | 372,39M | 291,07M | 232,63M | 174,24M | 114,81M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#3 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026